<VariationArchive VariationID="1456008" VariationName="NM_014363.6(SACS):c.12839del (p.Phe4280fs)" VariationType="Deletion" Accession="VCV001456008" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1380266" VariationID="1456008">
      <GeneList>
        <Gene Symbol="SACS" FullName="sacsin molecular chaperone" GeneID="26278" HGNC_ID="HGNC:10519" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q12.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="23328830" stop="23433702" display_start="23328830" display_stop="23433702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="23902964" stop="24007840" display_start="23902964" display_stop="24007840" Strand="-" />
          </Location>
          <OMIM>604490</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014363.6(SACS):c.12839del (p.Phe4280fs)</Name>
      <CanonicalSPDI>NC_000013.11:23331036:AAAA:AAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q12.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="23331037" stop="23331037" display_start="23331037" display_stop="23331037" variantLength="1" positionVCF="23331036" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="23905176" stop="23905176" display_start="23905176" display_stop="23905176" variantLength="1" positionVCF="23905175" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F4133fs</ProteinChange>
      <ProteinChange>F4280fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.23905179del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.23905179del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.23331040del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.23331040del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012342.1" sequenceAccession="NG_012342" sequenceVersion="1" change="g.107666del">
            <Expression>NG_012342.1:g.107666del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278055.2" sequenceAccession="NM_001278055" sequenceVersion="2" change="c.12398del">
            <Expression>NM_001278055.2:c.12398del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001264984.1" sequenceAccession="NP_001264984" sequenceVersion="1" change="p.Phe4133fs">
            <Expression>NP_001264984.1:p.Phe4133fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014363.6" sequenceAccession="NM_014363" sequenceVersion="6" change="c.12839del" MANESelect="true">
            <Expression>NM_014363.6:c.12839del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055178.3" sequenceAccession="NP_055178" sequenceVersion="3" change="p.Phe4280fs">
            <Expression>NP_055178.3:p.Phe4280fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1197238841" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014363.6(SACS):c.12839del (p.Phe4280fs) AND Spastic paraplegia" Accession="RCV001950930" Version="5">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014363.6(SACS):c.12839del (p.Phe4280fs) AND Charlevoix-Saguenay spastic ataxia" Accession="RCV003471168" Version="1">
        <ClassifiedConditionList TraitSetID="1544">
          <ClassifiedCondition DB="MedGen" ID="C1849140">Charlevoix-Saguenay spastic ataxia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-28" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31230722</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1544" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5931" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Charlevoix-Saguenay spastic ataxia</ElementValue>
                <XRef ID="MONDO:0010041" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive spastic ataxia of Charlevoix-Saguenay</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic ataxia of Charlevoix-Saguenay</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPAX6</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ARSACS</ElementValue>
                <XRef ID="NBK1255" DB="GeneReviews" />
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SACS</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is clinically characterized by a progressive cerebellar ataxia, peripheral neuropathy, and spasticity. Disease onset of classic ARSACS is often in early childhood, leading to delayed walking because of gait unsteadiness in very young toddlers, while an increasing number of individuals with disease onset in teenage or early-adult years are now being described. Typically the ataxia is followed by lower-limb spasticity and later by peripheral neuropathy â€“ although pronounced peripheral neuropathy has been observed as a first sign of ARSACS. Oculomotor disturbances, dysarthria, and upper-limb ataxia develop with slower progression than the other findings. Brain imaging demonstrates atrophy of the superior vermis and the cerebellar hemisphere with additional findings on MRI, such as linear hypointensities in the pons and hyperintense rims around the thalami. Many affected individuals (though not all) have yellow streaks of hypermyelinated fibers radiating from the edges of the optic disc noted on ophthalmologic exam, and thickened retinal fibers can be demonstrated by optical coherence tomography. Mild intellectual disability, hearing loss, and urinary urgency and incontinence have been reported in some individuals.</Attribute>
                <XRef ID="NBK1255" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4910" />
                <XRef ID="4910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301432</ID>
                <ID Source="BookShelf">NBK1255</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="98" DB="Orphanet" />
              <XRef ID="C1849140" DB="MedGen" />
              <XRef ID="MONDO:0010041" DB="MONDO" />
              <XRef Type="MIM" ID="270550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7856580" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_014363.6:c.12839del|OMIM:270550" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004210015" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_014363.6:c.12839del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="270550" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4251089" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="6280933|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002234348" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31230722</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the SACS protein in which other variant(s) (p.Tyr4538*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1456008). This variant is also known as c.12398delT, p.Phe4133Serfs*28. This premature translational stop signal has been observed in individual(s) with clinical features of hereditary spastic paraplegia (PMID: 31230722). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Phe4280Serfs*28) in the SACS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 300 amino acid(s) of the SACS protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.23905176del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7856580" TraitType="Disease" MappingType="XRef" MappingValue="270550" MappingRef="OMIM">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4251089" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

